Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Eur J Cancer. 2016 Jun 30;64:89–95. doi: 10.1016/j.ejca.2016.05.009

Table 2.

Discriminatory ability of raw-CPS, PaP-CPS, PaP-without CPS, PaP-total

Model Concordance index (95% CI) Area under the ROC curve (95% CI) for 30-day survival Area under the ROC curve (95% CI) for 100-day survival
Raw-CPS 0.58 (0.47, 0.68) 0.58 (0.47, 0.68) 0.62 (0.54, 0.70)
PaP-CPS 0.56 (0.46, 0.66) 0.57 (0.47, 0.67) 0.59 (0.51, 0.66)
PaP-without CPS 0.65 (0.55, 0.77) 0.78 (0.70, 0.87) 0.68 (0.61, 0.76)
PaP-total score 0.64 (0.54, 0.74) 0.73 (0.64, 0.82) 0.68 (0.60, 0.76)